Hypertrophic cardiomyopathy: Never-ending complexity;Miocardiopatía hipertrófica: La complejidad que no cesa

Revista Espanola de Cardiologia

Volumn 59, Issue 10, 2006, Pages 994-996

  Navarro López, Francesc ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS;

EID: 37849185591     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13093974     Document Type: Editorial

References (14)

1. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999-1006.
2. Roberts R, Sigwart U. New concepts in hypertrophic cardiomyopathy, part I. Circulation. 2001;104:2113-6.
3. Arad M, Seidman JG, Seidman CE. Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet. 2002;11:2499-506.
4. Navarro-López F. Miocardiopatía hipertrófica. Bases genéticas e implicaciones clínicas. Rev Esp Cardiol. 2004; 57 Supl 1:22-32.
5. Laredo R, Monserrat L, Hermida-Prieto M, Fernández X, Rodríguez I, Cazón L, et al. Mutaciones en el gen de la cadena pesada de la betamiosina en pacientes con miocardiopatía hipertrófica. Rev Esp Cardiol. 2006;59:1008-18.
6. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, et al. Hypertrophic cardiomyopathy. Distribution of disease genes, spectrum of mutations, and implications for molecular diagnosis estrategy. Circulation. 2003;107:2227-32.
7. Van Driest SL, Jaeger MA, Ommen SR, Hill ML, Gersh BJ, Tajik AJ. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44:602-10.
8. Jaaskelainen P, Miettinen R, Karkkainen P, Toivonen L, Laakso M, Kuusisto J. Genetics of hypertrophic cardiomyopathy in easter Finland: few founder mutations with benign or intermediate phenotypes. Ann Med. 2004;36:23-32.
9. Song L, Zou Y, Wang J, Wang Z, Zhen Y, Lou K, et al. Mutations profile in Chinese patients with hypertrophic cardiomyopathy. Clin Chim Acta. 2005;351:209-16.
10. García-Castro M, Reguero JR, Batalla A, Diaz-Molina B, González P, Álvarez V, et al. Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYC7) and cardiac troponin T (TNNT2) genes among Spanish patients. Clin Chem. 2003; 49:1279-85.
11. Van Driest SL, Vasile VC, Ommen SR, Hill ML, Tajik AJ, Gersh BJ. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004; 44:1903-10.
12. Enjuto M, Francino A, Navarro-López F, Viles D, Paré JC, Ballesta AM. Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in beta-myosin heavy chain gene. J Mol Cell Cardiol. 2000;32:2307-13.
13. Kirshner SE, Becker E, Antognozzi M, Kubis H-P, Francino A, Navarro-López F, et al. Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcum sensitivity with functional imbalances among individual muscle cells. Am J Physiol Heart Circ Physiol. 2005;288:1242-51.
14. Mora R, Merino JL, Peinado R, Olias F, García-Guereta L, Del Cerro MJ, et al. Miocardiopatía hipertrófica: baja frecuencia de mutaciones en el gen de la cadena pesada de la betamiosina cardiaca. Rev Esp Cardiol. 2006;59:846-9.